FOXO4-DRI

FOXO4-DRI is a synthetic peptide designed for research into cellular senescence, apoptosis signaling, and aging-related cellular dysfunction. It is derived from a segment of the FOXO4 protein and modified to disrupt the interaction between FOXO4 and p53, a pathway involved in the survival of senescent (aged or damaged) cells.

In laboratory research, FOXO4-DRI is commonly studied for its potential role in selectively influencing senescent cell behavior and promoting apoptosis in aged or dysfunctional cells. This has made it a notable compound in longevity science, regenerative biology, and age-related disease research models.

Key Features

• Synthetic peptide derived from FOXO4 protein interaction domain
• Designed to disrupt FOXO4–p53 binding in research models
• Commonly studied in cellular senescence and aging pathways
• Investigated for selective apoptosis of senescent cells
• Relevant to longevity and regenerative biology research

Common Research Areas

Researchers and scientific studies commonly explore FOXO4-DRI for:

• Cellular senescence and aging mechanisms
• Apoptosis signaling in damaged or aged cells
• Longevity and lifespan biology research
• Age-related tissue dysfunction models
• Regenerative and cellular turnover studies

Product Quality

Manufactured under strict quality control standards and tested for purity, identity, and consistency to ensure reliable research-grade material.

Disclaimer: This product is intended strictly for laboratory research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.